文章摘要
曹 睿,孟祥林,周燕萍,张晓春,付茂月,陈 昆,李鸷嵩,赵品勇,明 静.眩晕宁颗粒联合盐酸倍他司汀对VBIV患者动脉血流速度、氧化应激及血液流变学的影响[J].,2021,(10):1912-1915
眩晕宁颗粒联合盐酸倍他司汀对VBIV患者动脉血流速度、氧化应激及血液流变学的影响
The Effect of Xuanyunning Granule Combined with Betahistine on Arterial Blood Flow Velocity, Oxidative Stress and Hemorheology in VBIV
投稿时间:2020-09-23  修订日期:2020-10-18
DOI:10.13241/j.cnki.pmb.2021.10.023
中文关键词: 眩晕宁颗粒  盐酸倍他司汀  椎-基底动脉供血不足  眩晕症  动脉血流速度  氧化应激  血液流变学
英文关键词: Xuanyunning granules  Betahistine hydrochloride  Vertebrobasilar insufficiency  Vertigo  Arterial blood flow velocity  Oxidative stress  Hemorheology
基金项目:四川省卫生厅科技项目(16PJ1381)
作者单位E-mail
曹 睿 四川大学华西医院宜宾医院药学部 四川 宜宾 644099 htcaorui@163.com 
孟祥林 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
周燕萍 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
张晓春 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
付茂月 四川大学华西医院宜宾医院神经内科 四川 宜宾 644099  
陈 昆 西南医科大学附属医院药学部 四川 泸州 646000  
李鸷嵩 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
赵品勇 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
明 静 四川大学华西医院宜宾医院药学部 四川 宜宾 644099  
摘要点击次数: 658
全文下载次数: 521
中文摘要:
      摘要 目的:探讨眩晕宁颗粒联合盐酸倍他司汀对椎-基底动脉供血不足性眩晕症(VBIV)患者动脉血流速度、氧化应激及血液流变学的影响。方法:选取我院于2018年2月~2019年7月期间接收的360例VBIV患者。采用随机数字表法将患者分为研究组(n=180)、对照组(n=180),对照组予以盐酸倍他司汀治疗,研究组在对照组基础上联合眩晕宁颗粒治疗,比较两组患者疗效、动脉血流速度、氧化应激及血液流变学指标情况,记录两组不良反应发生率。结果:研究组治疗1个月后的临床总有效率为84.44%(152/180);高于对照组的66.11%(119/180)(P<0.05)。两组患者治疗1个月后左侧椎动脉、右侧椎动脉、基底动脉平均血流速度均升高,且研究组高于对照组(P<0.05)。两组患者治疗1个月后超氧化物歧化酶(SOD)升高,且研究组高于对照组(P<0.05);而丙二醛(MDA)则降低,且研究组低于对照组(P<0.05)。两组患者治疗1个月后红细胞聚集指数、红细胞压积、全血黏度均降低,且研究组低于对照组(P<0.05)。两组不良反应的发生率对比无差异(P>0.05)。结论:眩晕宁颗粒联合盐酸倍他司汀治疗VBIV,可减轻机体氧化应激,改善患者动脉血流速度及血液流变学,且不增加不良反应发生率,疗效显著。
英文摘要:
      ABSTRACT Objective: To investigate the effects of Xuanyunning granule combined with betahistine on arterial blood flow velocity, oxidative stress and hemorheology in vertebrobasilar insufficiency vertigo (VBIV). Methods: From February 2018 to July 2019, 390 patients with VBIV who were received by our hospital were selected. The patients were divided into study group (n=180) and control group (n=180) by random number table method. The control group was treated with betahistine hydrochloride. The study group was treated with Xuanyunning granule on the basis of the control group. The curative effect, arterial blood flow velocity, oxidative stress and hemorheology indexes of the two groups were compared, and the incidence of adverse reactions of the two groups was recorded. Results: The total effective rate of the study group after 1 month of treatment was 84.44% (152/180) and higher than 66.11% (119/180) of the control group (P<0.05). The mean blood flow velocity of left vertebral artery, right vertebral artery and basilar artery in the two groups increased at after 1 month of treatment, and the study group was higher than the control group (P<0.05). After 1 month of treatment, the superoxide dismutase (SOD) of the two groups increased, and the study group was higher than the control group (P<0.05), while the malondialdehyde (MDA) decreased, and the study group was lower than the control group (P<0.05). After 1 month of treatment, the red blood cell aggregation index, hematocrit and whole blood viscosity of the two groups decreased, and the study group was lower than the control group (P<0.05). There was no difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Xuanyunning granule combined with betahistine hydrochloride is effective in the treatment of VBIV, which can reduce the body's oxidative stress, improve the arterial blood flow velocity and hemorheology, and do not increase the incidence of adverse reactions, which has a good effect.
查看全文   查看/发表评论  下载PDF阅读器
关闭